HB 263 — AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO COST SHARING IN PRESCRIPTION INSULIN DRUGS.
Last action — Signed by Governor
-
✓Introduced
-
✓In Committee
-
✓Passed House
-
✓Passed Senate
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced January 09, 2020. Enacted.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Enacted
Current position in the legislative process.
-
31 sponsors
6 primary, 25 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (14 D · 1 R) — cross-party backing.
-
Cleared a recorded vote
Passed 2 recorded votes so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
Bill Text
What changed in the latest version
62 added · 54 removed62 line(s) added, 54 removed.
Minor-BrownDorsey HOUSEWalker OF& REPRESENTATIVESRep. 150th GENERAL ASSEMBLY HOUSE AMENDMENT NO.
1Minor-Brown TO& HOUSESen. BILL NO.
263Townsend AMEND& HouseSen. Bill No.
263Brown onReps. lines 10, 27, and 43 by inserting the following after “prescriptions.”:
“TheBaumbach, $100Bolden, perBrady, monthChukwuocha, capCooke, includesGriffith, deductibleHeffernan, paymentsJaques, andK. cost-sharing amounts charged once a deductible is met.”.
FURTHERJohnson, AMENDKowalko, HouseLonghurst, BillLynn, No.Mitchell, Osienski, Seigfried, Michael Smith, Viola, K.
263Williams; on lines 11, 28, and 44, by deleting “insulin” between “of” and “on” and inserting in lieu thereof “each of the following types of prescription insulin drugs”.
FURTHERSens. AMEND House Bill No.
263Lockman, onLopez, linesMcDowell, 12Paradee, andSokola, 29Sturgeon, byWalsh deletingHOUSE “carrier.”OF afterREPRESENTATIVES “the”150th andGENERAL insertingASSEMBLY inHOUSE lieuBILL thereofNO. the following:
“carrier:263 AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO COST SHARING IN PRESCRIPTION INSULIN DRUGS.
a.BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:
Rapid-acting.Section 1.
b.Amend Chapter 33, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:
Short-acting.§ 3344B.
b.Cost sharing in prescription insulin drugs.
Intermediate-acting.(a) For purposes of this section, “prescription insulin drug” means a drug containing insulin that is dispensed under Chapter 47 of Title 16 for the treatment of diabetes.
c.(b) An individual health insurance policy, contract, or certificate that is delivered, issued for delivery, renewed, extended, or modified in this State that provides coverage for prescription insulin drugs must do all of the following:
Long-acting.(1) Cap the total amount that a covered individual is required to pay for covered prescription insulin drugs at no more than $100 per month for each enrolled individual, regardless of the amount or types of insulin needed to fill the covered individual’s prescriptions.
(3)(2) ForInclude purposesat ofleast paragraph1 (b)(2)formulation of thisinsulin section,on the “lowestlowest tier of the drug formulary”formulary meansdeveloped eitherand ofmaintained by the following:carrier.
a.(c) Nothing in this section prevents the operation of a policy provision required by this section as a deductible, coinsurance, allowable charge limitation, coordination of benefits, or a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility.
If(d) theThis prescriptionsection insulinapplies drugto isall apolicies, genericcontracts, drug,or thecertificates lowestissued, tierrenewed, formodified, genericaltered, drugs.amended, or reissued after January 1, 2021.
b.Section 2.
IfAmend Chapter 35, Title 18 of the prescriptionDelaware insulinCode drugby ismaking adeletions brand-nameas drug,shown theby loweststrike tierthrough forand brand-nameinsertions drugs.”.as shown by underline as follows:
FURTHER§ AMEND3560A. House Bill No.
263Cost onsharing lines 13 and 30 by deleting “Nothing” between “(c)” and “in” and inserting in lieuprescription thereofinsulin thedrugs. following:
“Except as provided under paragraph (b)(1) of this section, nothing”.
FURTHER AMEND House Bill No.
263 on line 17 and 34 by deleting “January 1, 2021.” after “after” and inserting in lieu thereof “December 31, 2020.”.
FURTHER AMEND House Bill No.
263 on line 23 by deleting “An individual” between “(b)” and “health” and inserting in lieu thereof “A group or blanket”.
01/29/202001/09/2020 08:5808:13 AM FURTHER(a) AMENDFor Housepurposes Billof No.this section, “prescription insulin drug” means a drug containing insulin that is dispensed under Chapter 47 of Title 16 for the treatment of diabetes.
263(b) onAn lineindividual 45health byinsurance deletingpolicy, “carrier.”contract, afteror “the”certificate andthat insertingis delivered, issued for delivery, renewed, extended, or modified in lieuthis thereofState that provides coverage for prescription insulin drugs must do all of the following:
“carrier:(1) Cap the total amount that a covered individual is required to pay for covered prescription insulin drugs at no more than $100 per month for each enrolled individual, regardless of the amount or types of insulin needed to fill the covered individual’s prescriptions.
a.(2) Include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
Rapid-acting.(c) Nothing in this section prevents the operation of a policy provision required by this section as a deductible, coinsurance, allowable charge limitation, coordination of benefits, or a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility.
b.(d) This section applies to all policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued after January 1, 2021.
Short-acting.Section 3.
b.Amend Chapter 52, Title 29 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:
Intermediate-acting.§ 5212.
c.Cost sharing in prescription insulin drugs.
Show all 62 changed lines (22 more)
Long-acting.(a) For purposes of this section, “prescription insulin drug” means a drug containing insulin that is dispensed under Chapter 47 of Title 16 for the treatment of diabetes.
(3)(b) ForThe purposesplan ofmust paragraphprovide (b)(2)coverage offor thisprescription section,insulin thedrugs “lowestthat tierdoes ofall the drug formulary” means either of the following:
a.(1) Caps the total amount that a covered individual is required to pay for covered prescription insulin drugs at no more than $100 per month for each enrolled individual, regardless of the amount or types of insulin needed to fill the covered individual’s prescriptions.
If(2) theIncludes prescriptionat insulinleast drug1 isformulation aof genericinsulin drug,on the lowest tier forof genericthe drugs.drug formulary developed and maintained by the carrier.
b.SYNOPSIS This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
If the prescription insulin drug is a brand-name drug, the lowest tier for brand-name drugs.
(c) The cap on the amount a covered individual is required to pay under paragraph (b)(1) of this section applies to an enrolled individual who is in compliance with all coordination of benefits policies of the plan, including spousal coordination of benefits.”.
SYNOPSIS This Amendment revises House Bill No.
263 by doing all of the following:
1.
Requires at least 1 formulation of each type of prescription insulin be on the lowest tier of the drug formulary.
2.
Defines the "lowest tier of the drug formulary" as the lowest tier for generic drugs, if the insulin is a generic and the lowest tier for brand-name drugs, if the insulin is brand-name.
3.
Clarifies that the $100 per month cost-sharing cap includes deductible payments and cost-sharing amounts charged once a deductible is met.
4.
Corrects the date for the applicability of this Act so it includes insurance plans that begin on January 1, 2021.
5.
Clarifies that the cap on the copay applies to covered individuals who are in compliance with the coordination of benefits policies under the State employee insurance plans.
6.
Corrects a typographical error.
01/29/202001/09/2020 08:5808:13 AM 59715002625971500224
Show all 62 changed rows (22 more)
Action History
-
Signed by Governor
-
Suspension of Rules in Senate
-
Passed By Senate. Votes: 21 YES
-
Assigned to Health & Social Services Committee in Senate
-
Passed By House. Votes: 40 YES 1 ABSENT
-
Amendment HA 2 to HB 263 - Stricken in House
-
Amendment HA 1 to HB 263 - Passed In House by Voice Vote
-
Amendment HA 2 to HB 263 - Introduced and Placed With Bill
-
Amendment HA 1 to HB 263 - Introduced and Placed With Bill
-
Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 4 On Its Merits
-
Introduced and Assigned to Health & Human Development Committee in House
Sponsors
- Kimberly Williams · Cosponsor
- Michael F. Smith · Cosponsor
- Edward S. Osienski · Cosponsor
- Sean M. Lynn · Cosponsor
- Kendra Johnson · Cosponsor
- Debra Heffernan · Cosponsor
- Krista Griffith · Cosponsor
- Franklin D. Cooke · Cosponsor
- Nnamdi O. Chukwuocha · Cosponsor
- Stephanie T. Bolden · Cosponsor
- John "Jack" Walsh · Cosponsor
- Laura V. Sturgeon · Cosponsor
- David P. Sokola · Cosponsor
- Trey Paradee · Cosponsor
- S. Elizabeth Lockman · Cosponsor
- Melissa Minor-Brown · Primary
- Darius J. Brown · Primary
- Bryan Townsend · Primary
- Gerald L. Brady · Cosponsor
- Earl G. Jaques Jr. · Cosponsor
- John A. Kowalko · Cosponsor
- Valerie Longhurst · Cosponsor
- David Bentz · Primary
- Andria L. Bennett · Primary
- Sherry Dorsey Walker · Primary
- Ernesto B Lopez · Cosponsor
- Harris B. McDowell · Cosponsor
- Paul S. Baumbach · Cosponsor
- John L. Mitchell · Cosponsor
- Raymond Seigfried · Cosponsor
- John J. Viola · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →6 sponsors · 25 co-sponsors · 31 not signed on
Sponsors (6)
- Melissa Minor-Brown Democratic
- Darius J. Brown Democratic
- Bryan Townsend Democratic
- David Bentz
- Andria L. Bennett
- Sherry Dorsey Walker
Co-sponsors (25)
- Kimberly Williams Democratic
- Michael F. Smith Republican
- Edward S. Osienski Democratic
- Sean M. Lynn Democratic
- Kendra Johnson Democratic
- Debra Heffernan Democratic
- Krista Griffith Democratic
- Franklin D. Cooke Democratic
- Nnamdi O. Chukwuocha Democratic
- Stephanie T. Bolden Democratic
- John "Jack" Walsh
- Laura V. Sturgeon
- David P. Sokola Democratic
- Trey Paradee
- S. Elizabeth Lockman Democratic
- Gerald L. Brady
- Earl G. Jaques Jr.
- John A. Kowalko
- Valerie Longhurst
- Ernesto B Lopez
- Harris B. McDowell
- Paul S. Baumbach
- John L. Mitchell
- Raymond Seigfried
- John J. Viola
Not signed on (31)
31 members have not signed on to this bill.
Show all 31 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 7 | 0 | 0 | 0 |
| Democratic | 9 | 0 | 0 | 0 |
| Republican | 5 | 0 | 0 | 0 |
| Total | 21 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (21)
| Member | Party | Vote |
|---|---|---|
| Anthony Delcollo | — | Yea |
| Bruce C. Ennis | — | Yea |
| Catherine Cloutier | — | Yea |
| Colin Bonini | — | Yea |
| David B. McBride | — | Yea |
| Ernesto B Lopez | — | Yea |
| Harris B. McDowell | — | Yea |
| Bryan Townsend | Democratic | Yea |
| Darius J. Brown | Democratic | Yea |
| David P. Sokola | Democratic | Yea |
| John "Jack" Walsh | Democratic | Yea |
| Laura V. Sturgeon | Democratic | Yea |
| Nicole Poore | Democratic | Yea |
| S. Elizabeth Lockman | Democratic | Yea |
| Stephanie L. Hansen | Democratic | Yea |
| Trey Paradee | Democratic | Yea |
| Brian Pettyjohn | Republican | Yea |
| Bryant L. Richardson | Republican | Yea |
| Dave G. Lawson | Republican | Yea |
| David L. Wilson | Republican | Yea |
| Gerald W. Hocker | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 16 | 0 | 0 | 1 |
| Democratic | 12 | 0 | 0 | 0 |
| Republican | 12 | 0 | 0 | 0 |
| Total | 40 | 0 | 0 | 1 |
| % of votes cast | 98% | 0% | 0% | 2% |
How each member voted (41)
Subjects
Frequently asked questions
- What does HB 263 do?
- This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
- Who sponsors HB 263?
- HB 263 is sponsored by Kimberly Williams (Democratic), Michael F. Smith (Republican), Edward S. Osienski (Democratic), Sean M. Lynn (Democratic), Kendra Johnson (Democratic), Debra Heffernan (Democratic), Krista Griffith (Democratic), Franklin D. Cooke (Democratic), Nnamdi O. Chukwuocha (Democratic), Stephanie T. Bolden (Democratic), John "Jack" Walsh, Laura V. Sturgeon, David P. Sokola (Democratic), Trey Paradee, S. Elizabeth Lockman (Democratic), Melissa Minor-Brown (Democratic), Darius J. Brown (Democratic), Bryan Townsend (Democratic), Gerald L. Brady, Earl G. Jaques Jr., John A. Kowalko, Valerie Longhurst, David Bentz, Andria L. Bennett, Sherry Dorsey Walker, Ernesto B Lopez, Harris B. McDowell, Paul S. Baumbach, John L. Mitchell, Raymond Seigfried, and John J. Viola.
- What is the current status of HB 263?
- This bill has been enacted into law. Introduced January 09, 2020. Enacted.
- Where can I track HB 263?
- Track HB 263 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 263
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 263
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →